Why Quest Diagnostics Stock Climbed This Past Week
Shares of Quest Diagnostics (NYSE: DGX) rose more than 8% last week after the medical testing leader boosted its full-year sales and profit forecast.
Image source: Getty Images.
Quest's revenue jumped 10% year over year to $3 billion in the second quarter.
Source Fool.com
